Lung/Thoracic Oncology News & Articles

1 The value of pleural lavage cytology examined during surgery for primary lung cancer European Journal of Cardio-Thoracic Surgery, May 23, 2012

2 A Study of ΔNp63 Expression in Lung Non-Small Cell Carcinomas American Journal of Surgical Pathology , May 23, 2012

3 Case report: lymphoepithelial-like carcinoma of the lung-a chronic disease World Journal of Surgical Oncology, May 23, 2012

4 Bronchial carcinoma after lung transplantation: A single-center experience The Journal of Heart and Lung Transplantation, May 23, 2012

5 Which platform to support a personalized lung cancer treatment Bulletin du Cancer, May 23, 2012

6 Mediastinal lymph node dissection in early-stage non-small cell lung cancer: totally thoracoscopic vs thoracotomy European Journal of Cardio-Thoracic Surgery, May 23, 2012

7 The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer European Journal of Cardio-Thoracic Surgery, May 23, 2012

8 The Efficacy of PET Staging for Small-Cell Lung Cancer: A Systematic Review and Cost Analysis in the Australian Setting Journal of Thoracic Oncology, May 22, 2012    Evidence Based Medicine

9 Diagnostic and Prognostic Impact of Serum Soluble UL16-Binding Protein 2 in Lung Cancer Patients Cancer Science, May 22, 2012

10 Tissue-Sparing Application of the Newly Proposed IASLC/ATS/ERS Classification of Adenocarcinoma of the Lung Shows Practical Diagnostic and Prognostic Impact American Journal of Clinical Pathology, May 22, 2012

11 Duration of Voriconazole Exposure: An Independent Risk Factor for Skin Cancer After Lung Transplantation Dermatologic Surgery, May 22, 2012

12 Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC) Lung Cancer, May 22, 2012

13 Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study Lung Cancer, May 22, 2012

14 ALK-Mutated Non-Small-Cell Lung Cancer: A New Strategy for Cancer Treatment Lung, May 22, 2012

15 Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials Lung Cancer, May 22, 2012    Evidence Based Medicine

16 Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy Lung Cancer, May 22, 2012

17 Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas Cancer, May 21, 2012

18 Defining a Gene Promoter Methylation Signature in Sputum for Lung Cancer Risk Assessment Clinical Cancer Research, May 21, 2012

19 Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma Cancer Research, May 21, 2012

20 SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model Respirology, May 21, 2012

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012

2 Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group Lung Cancer, March 19, 2012

3 Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy The Lancet Oncology - Online First, March 27, 2012

4 Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients Lung Cancer, April 4, 2012

5 Phase 2 study of single agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer Clinical Cancer Research, April 13, 2012

6 Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib Clinical Cancer Research, April 9, 2012

7 EGFR mutations as a predictive marker of cytotoxic chemotherapy Lung Cancer, April 26, 2012

8 Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial The Lancet Oncology - Online First, April 20, 2012

9 Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA, April 19, 2012

10 A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma Modern Pathology, April 16, 2012

11 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012

12 Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy Cancer, April 17, 2012

13 First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung Journal of Clinical Oncology, April 5, 2012

14 Intensive care unit outcomes among patients with lung cancer in the Surveillance, Epidemiology, and End Results-Medicare Registry Journal of Clinical Oncology, April 9, 2012

15 Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study Lung Cancer, April 13, 2012

16 Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer Cancer, April 17, 2012

17 Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer Lung Cancer, March 16, 2012

18 Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies International Journal of Cancer, April 23, 2012

19 Generalisability of the results of the Dutch–Belgian randomised controlled lung cancer CT screening trial (NELSON): Does self-selection play a role Lung Cancer, April 2, 2012

20 Nedaplatin and Irinotecan in Patients with Large-cell Neuroendocrine Carcinoma of the Lung Anticancer Research, April 11, 2012